Abstract U.S. firms have reduced their investment in scientific research ("R") compared to product development ("D …"), raising questions about the returns to each type of investment, and about the reasons for this shift. We use Census data that … disaggregates "R" from "D" to study how US firms adjust their innovation investments in response to an external increase in funding …

-term performance. We investigate 495 transactions with a focus on one form of long-term activities, namely investments in innovation as …

returns, with an out-of-sample R2 of 1.35%, and negatively predicts returns on short-term government and investment …

We present a model of endogenous firm growth with R&D investment and stochastic innovation as the engines of growth …) firm growth independent of firm size, as stated in the so-called Gibrat's law, and (iii) R&D investment proportional to …

Prior literature has established a link between changes in market size and pharmaceutical innovation; whether a link … conducting applied research. Implications for pharmaceutical innovation policy are discussed …

to CNC increased capital investment and experienced higher labor productivity. Total employment rose, with gains for …

This paper is a contribution to the small but growing literature that compares the investment and R&D behavior of … of a simple error-corrected investment model for both ordinary investment and for R&D investment, a model that … incorporates both output (sales or turnover) and cash flow as predictors for investment. Our focus is on two comparisons: France …

decrease their R&D spending (our main proxy for long-term investment) more than Japanese firms. We find no evidence that this …